SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Tabletting, coating & ancillary equipment

News headlines

CDMO Recro expands manufacturing capabilities at former Alkermes site

24-May-2017 - Recro has added a new tablet manufacturing suite that enables it to compress single- and bi-layer tablets at commercial speeds.

Coming to America: Evolving pharma landscape brings CPhI to Philadelphia

16-May-2017 - With almost 40% of attendees coming from outside the US, the political climate has had no effect on the latest CPhI franchise which starts today in Philadelphia.

H&T Presspart buys rights to Hovione inhaler tech

27-Apr-2017 - H&T Presspart has bought the rights to manufacture and commercialise a capsule-based dry powder inhaler (DPI) from Hovione.

DISPATCHES FROM BPI EUROPE 2017

Messenger RNA a ‘game-changer’ for vaccine industry, Sanofi Pasteur

26-Apr-2017 - Sanofi Pasteur says heavy investment in messenger RNA (mRNA) is warranted as such technology could revolutionise vaccine development and manufacturing.

Compounding firm looks at NDA opportunity for reformulation of Mallinckrodt's H.P. Acthar

23-Mar-2017 - Imprimis Pharmaceuticals says it is evaluating pursuing New Drug Application (NDA) status for some of its product reformulations through the US FDA 505(b)(2) development pathway.

Keryx: Patheon and Norwich sites will ensure supply of iron-based Auryxia

06-Mar-2017 - Keryx Biopharmaceuticals will continue to work with Norwich Pharmaceuticals despite bringing Patheon on board to manufacture Auryxia (ferric citrate).

Turmeric bioavailability enhancer could be used with APIs, Wacker

02-Mar-2017 - Wacker Biosolutions says an excipient shown to increase the bioavailability of a food supplement by a factor of 40 could have implications in the API space.

Allergan's €42m investment boosts Irish manufacturing and jobs

02-Mar-2017 - Allergan has committed €42m ($44m) to increase capacity and capabilities at two manufacturing facilities in Ireland.

Cardboard and brown agglomerates: FDA slams Pfizer injectables plant

01-Mar-2017 - Particulate problems in sterile injectables and poor aseptic techniques landed Pfizer with a US FDA warning letter at a former Hospira facility in Kansas.

Baxter and ScinoPharm sign injectable oncology drug strategic alliance

01-Mar-2017 - Up to 20 injectable cancer drugs will be made at facilities in Taiwan and Germany under terms of a partnership between Baxter and Scinopharm.

Pfizer hit with US FDA warning at Kansas generic Copaxone site

20-Feb-2017 - The US FDA has issued a warning letter to the former Hospira fill and finish facility in McPherson, Kansas – now part of Pfizer’s contract manufacturing business CentreOne.

Is the return of the one-stop-shop model just a CMO marketing ploy?

16-Feb-2017 - End-to end service offerings are a differentiator within the fragmented CMO industry and not driven by pharma demand, a Results Healthcare report says.

Quotient buys QS Pharma in latest US expansion move

15-Feb-2017 - Quotient Clinical Ltd. has bought Charles River Laboratories’ contract manufacturing business, QS Pharma LLC.

GSK on America First: US will not be able to own every part of supply chain

13-Feb-2017 - GSK has warned that Donald Trump’s plan to encourage US drug production through import tax hikes must take the global nature of pharma supply chains into account.

GEA takes €18m hit from 'unexpected' pharma cancellation in 2016

08-Feb-2017 - Sales within the pharma division of German engineering firm GEA were down in 2016, partly due to an unexpected €18m contract cancellation.

Ferring licenses Enteris Peptelligence to turn injectable into oral drug

30-Jan-2017 - Ferring is the third company in a week which will use Enteris BioPharma’s Peptelligence engineering platform for small molecules to develop oral formulations.

Improving solubility: MilliporeSigma opens dedicated meglumine site

19-Jan-2017 - MilliporeSigma has opened a facility in Spain dedicated to the manufacture of the solubility-enhancing excipient meglumine.

Catalent to assess resveratrol formulation across softgel platforms

11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.

T-ray technique faster for tablet quality and structure testing say researchers

11-Jan-2017 - High frequency radiation can be used to test tablet quality and structural characteristics on the production line according to scientists planning to develop low cost THz sensors. 

US DEA finalises controlled substance and equipment revisions

09-Jan-2017 - Drugmakers must include a transaction identification number when buying or selling machinery for tabletting or encapsulating controlled substances, according to a final ruling from the US DEA.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Product Innovation